期刊文献+

脂联素对高糖培养的大鼠肾小球系膜细胞血管内皮生长因子表达的影响 被引量:1

Effect of Adiponectin on the Expression of Vascular Endothelial Growth Factor in High Glucose-cultured Rat Mesangial Cells
下载PDF
导出
摘要 目的观察脂联素对高糖培养的大鼠肾小球系膜细胞表达血管内皮生长因子(VEGF)的影响,探讨脂联素在糖尿病肾病中可能的保护作用。方法体外培养大鼠肾小球系膜细胞,随机分为7组:对照组、高糖A组、高糖B组(培养液葡萄糖浓度分别为5.6 mmol/L、15 mmol/L、30 mmol/L);脂联素A、B、C、D组(各组培养液葡萄糖浓度均为30 mmol/L+脂联素,脂联素浓度依次为2.5μg/ml、5μg/ml、10μg/ml、20μg/ml),作用24 h,RT-PCR法测定各组细胞VEGF mRNA表达水平;ELISA法测定各组上清液中VEGF蛋白的含量。结果与对照组相比,高糖A组、高糖B组大鼠肾小球系膜细胞VEGF mRNA及VEGF蛋白表达升高(P<0.05);脂联素各组大鼠肾小球系膜细胞VEGF mRNA及VEGF蛋白表达低于高糖B组(P<0.05)。结论高糖可刺激大鼠肾系膜细胞VEGF表达增高,脂联素可抑制高糖环境下系膜细胞对VEGF的表达。 Objective To observation the effect of adiponectin(ADPN) on vascular endothelial growth factor (VEGF) expressed by high glucose-cultured rat mesangial cell line(HBZY-1 ),and explore its protective role in diabetic nephropathy mechanism. Methods HBZY-1 was cultured in vitro, which was randomly divided into the following seven groups after the subculture :control group(5.6 mmol/L glucose),high glucose group A( 15 mmol/L glucose),high glucose group B(30 mmol/L glucose) ; Adiponectin group A, B, C, D with the concentration of 2.5,5,10,20 μg/ml adiponectin (30 mmol/L glucose in each group) ,respectively ;All the groups were treated for 24 hours. The expressions of VEGF mRNA in cells of each group were measured with RT-PCR,and the protein levels of VEGF were measured in each group with ELISA. Results Compared with control group, VEGF mRNA and VEGF protein expression of HBZY-1 increased in high glucose group A ,B (P 〈0.05) ;VEGF mRNA and VEGF protein expression of HBZY-1 in each adiponectin group were lower than those in high glucose group B (P 〈 0. 05). Conclusion High glucose can stimulate the increase of VEGF expression of HBZY-1 ,and ADPN can inhibit VEGF expression of high glucose-cultured mesangial cells.
出处 《广西医学》 CAS 2012年第7期810-812,共3页 Guangxi Medical Journal
基金 广西教育厅课题资助项目(201010LX043) 广西医科大学研究生教育创新计划项目(2010105981002M179) 广西医药卫生科研课题(桂卫Z2011322) 广西医学科学实验中心开放基金专项项目(KFJJ2011-29)
关键词 糖尿病肾病 大鼠 肾小球系膜细胞 血管内皮生长因子 脂联素 Diabetic nephropathy Mesangial cells Vascular endothelial growth factor Adiponectin
  • 相关文献

参考文献7

  • 1黄颂敏,陈泽君,杨亦彬,付平,柳飞,张翥,苏克亮.血管生成素及其受体、血管内皮生长因子与糖尿病肾脏微血管病变的关系[J].中华肾脏病杂志,2006,22(9):521-527. 被引量:26
  • 2Ohashi K, Iwatani H, Kihara S, et al. Exacerbation of albu- minuria and renal fibrosis in subtotal renal ablation model of adiponectin-knockout mice [ J ]. Arterioscler Thromb Vasc Biol,2007,27 (9) : 1 910 - 1 917.
  • 3李学军.糖尿病微血管病变发病机制研究新进展[J].临床医药实践,2008,17(4):245-247. 被引量:12
  • 4Kim NH, Kim KB, Kim DL, et al. Plasma and urinary vas- cular endothelial growth factor and diabetic nephropathy in Type 2 diabetes mellitus [ J ]. Diabet Med, 2004,21 ( 6 ) : 545 - 551.
  • 5Yilmaz MI, Sonmez A, Caglar K, et al. Effect of antihyper- tensive agents on plasma adiponeetin levels in hypertensive patients with metabolic syndrome[ J]. Nephrology( Carlton), 2007,12(2) :147 - 153.
  • 6Ran J, Xiong X, Liu W, et al. Increased plasma adiponeetin closely associates with vascular endothelial dysfunction in type 2 diabetic patients with diabetic nephropathy [ J ]. Diabetes Res Clin Pract, 2010,88 ( 2 ) : 177 - 183.
  • 7Koshimura J, Fujita H, Narita T, et al. Urinary adiponectin excretion is increased in patients with overt diabetic ne- phropathy[ J]. Biochem Biophys Res Commun, 2004, 316 (1) :165 - 169.

二级参考文献39

  • 1Flyvbjerg A.Putative pathophysiological role of growth factors and cytokines in experimental diabetic kidney disease.Diabetologia,2000,43:1205-1223.
  • 2Yancopoulos GD,Davis S,Gale NW,et al.Vascular-specific growth factors and blood vessel formation.Nature,2000,407(6801):242-248.
  • 3Abdulmalek K,Ashur F,Ezer N,et al.Differential expression of Tie-2 receptors and angiopoietins in response to in vivo hypoxia in rats.Am J Physiol Lung Cell Mol Physiol,2001,281:L582-L590.
  • 4Yamamoto Y,Maeshima Y,Kitayama H,et al.Tumstatin peptide,an inhibitor of angiogenesis,prevents glomerular hypertrophy in the early stage of diabetic nephropathy.Diabetes,2004,53:1831-1840.
  • 5Osterby R,Asplund J,Bangstad HJ,et al.Neovascularization at the vascular pole region in diabetic glomerulopathy.Nephrol Dial Transplant,1999,14:348-352.
  • 6Satchell SC,Mathieson PW.Angiopoietins:microvascular modulators with potential roles in glomerular pathophysiology.J Nephrol,2003,16:168-178.
  • 7Padro T,Ruiz S,Bieker R,et al.Increased angiogenesis in the bone marrow of patients with acute myeloid leukemia.Blood,2000,95:2637-2644.
  • 8Khamaisi M,Schrijvers BF,De Vriese AS,et al.The emerging role of VEGF in diabetic kidney disease.Nephrol Dial Transplant,2003,18:1427-1430.
  • 9Thurston C,Suri C,Smith K,et al.Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1.Science,1999,286(5449):2511-2514.
  • 10Enholm B,Paavonen K,Ristimaki A,et al.Comparison of VEGF,VEGF-B,VEGF-C and Ang-1 mRNA regulation by serum,growth factors,oncoproteins and hypoxia.Oncogene,1997,14:2475 -2483.

共引文献36

同被引文献3

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部